Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
40%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
PJP
31
HOLDINGS
37%
ALSO IN MEDX
MEDX
27
HOLDINGS
37%
ALSO IN PJP
SECTOR DRIFT (PJP minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 6.1% | 21.2% | 6.1% |
|
ABBVIE INC | 5.9% | 10.1% | 5.9% |
|
JOHNSON & JOHNSON | 5.3% | 5.8% | 5.3% |
|
AMGEN INC | 5.6% | 4.9% | 4.9% |
|
MERCK & CO. INC. | 5.1% | 4.5% | 4.5% |
PJP Overweight Relative to MEDX
|
GILEAD SCIENCES INC | 6.1% |
|
ABBOTT LABORATORIES | 4.9% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | 3.6% |
|
UNITED THERAPEUTICS CORP | 3.5% |
|
LIGAND PHARMACEUTICALS-CL B | 3.5% |
 |
PERRIGO CO | 3.3% |
|
TARSUS PHARMACEUTICALS, INC. | 3.2% |
|
VIATRIS, INC. | 3.1% |
|
INNOVIVA, INC. | 3.0% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | 3.0% |
PJP Underweight Relative to MEDX
|
ELI LILLY & CO | -15.1% |
 |
NOVARTIS AG-ADR | -6.9% |
 |
ASTRAZENECA PLC | -4.8% |
|
ALKERMES PLC | -4.6% |
|
ABBVIE INC | -4.2% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.5% |
|
CRISPR THERAPEUTICS AG | -2.4% |
|
IONIS PHARMACEUTICALS, INC. | -2.4% |
|
ALNYLAM PHARMACEUTICALS INC | -1.8% |
|
BRISTOL-MYERS SQUIBB CO | -1.4% |